Two commercially available HIV antigen assays (Abbott HTLV III Antigen test and the DuPont HIV p24 test) are widely used for these assays. We have previously tested asymptomatic HIV antibody positive homosexual men using both tests, and shown only "fair" agreement between the results of the two tests.6 In this study we examined the relative sensitivities and molecular specificities of the assays in an attempt to account for the discrepancies between the tests.
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Methods

SENSITIVITY AND CALIBRATION OF THE ASSAYS
A series of dilutions were made from a viral lysate containing 200 ng/ml p24 (800 ng/ml total HIV protein) (EI DuPont de Nemours and Co.). The resultant solutions were tested (in duplicate) in both ELISA systems using the manufacturer's protocol. By incorporating each ELISA's own test standards, each assay could also be calibrated against the known antigen titre.
SPECIFICITY OF THE ASSAYS
Western blotting of the rabbit detector antibody Nitrocellulose strips with pre-electrophoresed HIV proteins (BioRad Laboratories Ltd, Watford) were washed on a side to side rocker for two hours in phosphate buffered saline (PBS) containing 5% bovine serum albumin (BSA). The strips were then incubated overnight with 1-5 ml of detector antibody in 1-5 ml PBS containing 1% BSA and 0-05% Tween 20.
After washing three times in PBS the strips were incubated for two hours at room temperature with a 1 in 250 dilution of anti-rabbit IgG biotin conjugate (Amersham). The strips were rewashed three times in PBS and reincubated for two hours at room temperature in a 1 in 250 dilution of streptavidin-horseradish peroxidase (Amersham). After final washes in PBS the colour was developed using 1 volume of 3 mg/ml 4-chloro-l-naphthol in methanol and 5 volumes of TRIS buffered saline containing 0-003% H202.
Synthetic peptides A synthetic 104mer peptide7 (104 amino acids from the C-terminus of p24) was assayed in both the Abbott and DuPont HIV ELISAs to detect their relative sensitivities to this gag protein. A synthetic RNAse was used as a control preparation for these experiments.
To determine the key epitopes involved in binding, competitive blocking of epitopes was attempted using short synthetic peptides (15 band at p24. The Abbott strip showed a similar band at p24, but also bands at p18, p41-43, and a very weak band at gpl20.
Synthetic 104mer peptide
The Abbott test could detect about 400 pg/ml of the 104mer; the DuPont test could detect about 100 pg/ml (table 2) . The Abbott test became saturated at 8 ng/ml 104mer, and despite raising the concentration to 1000 ng/ml the optical density did not approach the reading of the Abbott positive control.
In the DuPont assay about 1-3 ng/ml of the 104mer was equivalent to the 250 pg/ml positive control (or 480 pg/ml p24 using the conversion factor calculated above).
The results for the competitive blocking using short peptides are given in gests that the Abbott and the DuPont tests recognise different antigenic epitopes, at least, on the core protein. This may in part explain the differences in the results of testing sera in the two assays. An alternative explanation for these results is that, although both Abbott and DuPont tests may recognise the same p24 epitope, the peptides failed to block the binding of the polyclonal Abbott antibody.
In conclusion, the two tests have different specificities and seem to detect different antigens. This may not be important in systems such as cell culture supernatant, where the antigens are produced in roughly fixed proportions. It may be very different in the detection of antigen in human sera, however, where the absence or presence of antibody may change the amount of antigen available for detection.
Similarly, the threefold variation in the quantification of antigen recorded by the two assays is disturbing. Again this is not as important if the tests are simply being used to tell if a cell culture is positive or negative for antigen, but may have repercussions if antigen titres are used to help decide on antiviral treatment. Conversely, in some clinical situations, such as determining whether primary infection has taken place, or in congenital infection, the antibody and antigen concentrations may be less important, and any concentrations of antigen be diagnostic. 
